In Vivo Delivery of Human Acid Ceramidase via Cord Blood Transplantation and Direct Injection of Lentivirus as Novel Treatment Approaches for Farber Disease

Molecular Genetics and Metabolism - United States
doi 10.1016/j.ymgme.2008.08.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Bone Marrow Transplantation for Infantile Ceramidase Deficiency (Farber Disease)

Bone Marrow Transplantation
TransplantationHematology
2000English

Identification of Cystatin SA as a Novel Inhibitor of Acid Ceramidase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2011English

Farber Disease Misdiagnosed as Hemangioendothelioma

Journal of the Korean Association of Pediatric Surgeons
2016English

Purification, Characterization, and Biosynthesis of Human Acid Ceramidase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Autoproteolytic Cleavage and Activation of Human Acid Ceramidase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2008English

Umbilical Cord Blood Transplantation for Children With Thalassemia and Sickle Cell Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2011English

Umbilical Cord Blood Transplantation and Umbilical Cord Blood Bank.

Journal of the Japan Society of Blood Transfusion
1998English

Umbilical Cord Blood-Derived Therapies as a Treatment for Graft-Versus-Host Disease

2017English

Ex Vivo Expansion of Human Umbilical Cord Blood-Derived T-Lymphocytes With Homologous Cord Blood Plasma

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy